March 11, 2020
Faller Packaging goes on tour with seminar
@augustfalleraugustfaller goes on tour with a seminar
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
March 5, 2020
Amunix nets $73M in Series A financing round
Amunix Pharmaceuticals, a tumor cancer-focused biopharmaceutical company has completed $73 million Series A financing round.
March 5, 2020
GenomSys moves to Biopôle in Lausanne
GenomSys has moved two of its teams to the BioPôle in Lausanne, to support the company’s growth and improve its accessibility to the Life Sciences community.
February 27, 2020
Abivax doses first patient with ABX196, an iNKT agonist, in combination with Opdivo
Abivax has doest the first patient with an iNKT agonist, ABX196, in a Phase 1/2 study to evaluate safety, tolerability and preliminary efficacy of the combination therapy. ABX196 is Abivax’s second compound in clinical development, following its lead candidate ABX464 in inflammatory diseases.
February 19, 2020
Mereo BioPharma gets investment of $3 Million
Mereo BioPharma has entered into a Securities Purchase Agreement with a new U.S.-based institutional healthcare investor. Under the terms of the Agreement, the institutional investor has agreed to make an investment of $3 million to purchase 12,252,715 of the Company’s ordinary shares (equivalent to 2,450,543 American Depository shares (ADSs)) at a price equivalent to 18.8 pence per share, which represents a 20% discount over Mereo’s closing share price of 23.5 pence on AIM on February 18, 2020.
February 10, 2020
Arctoris, Molecule to tackle the innovation crisis in drug discovery and development
Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug…
February 10, 2020
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products, has announced an agreement with Pfeiffer Vacuum Technologies to provide characterization testing of container-closure systems for the biopharma industry.
January 28, 2020
Adverum Biotechnologies opens new HQ in Redwood City, San Francisco
Clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, Adverum Biotechnologies on Tuesday announced the opening of its new corporate headquarters at one of the largest biotechnology research complexes in the San Francisco Bay Area.
January 27, 2020
Affiris to proceed with P2study with lead treatment for Parkinson’s
AFFiRiS AG, a clinical-stage biopharmaceutical company developing novel disease-modifying specific active immunotherapies (SAITs) for patients with neurodegenerative diseases, will proceed with the preparations for the planned phase 2 study and confirms its intended initiation in the US and Europe in the second half of 2020.
December 20, 2019
Hutschison China MediTech get’s priority review status for its anti-cancer drug surufatinib
Hutchison China MediTech Limited said on Friday that it got approval from the China’s authority, the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA), a Priority Review status to the New Drug Application (NDA) for surufatinib, for the treatment of patients with advanced non-pancreatic neuroendocrine tumors (NET).